Assessment of Tumor Regression by Consecutive Pelvic Magnetic Resonance Imaging and Dose Modification during High-Dose-Rate Brachytherapy for Carcinoma of the Uterine Cervix
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.